IRIS Accounts Production v26.1.10.60 10342832 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 165 83 87500 76710 88823 76792 1488 165 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh103428322025-03-31103428322026-03-31103428322025-04-012026-03-31103428322024-03-31103428322024-04-012025-03-31103428322025-03-3110342832ns15:EnglandWales2025-04-012026-03-3110342832ns14:PoundSterling2025-04-012026-03-3110342832ns10:Director12025-04-012026-03-3110342832ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3110342832ns10:SmallEntities2025-04-012026-03-3110342832ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3110342832ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3110342832ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3110342832ns10:FullAccounts2025-04-012026-03-3110342832ns10:OrdinaryShareClass12025-04-012026-03-3110342832ns10:OrdinaryShareClass22025-04-012026-03-3110342832ns10:OrdinaryShareClass32025-04-012026-03-3110342832ns10:OrdinaryShareClass42025-04-012026-03-311034283242ns10:Director22025-03-311034283242ns10:Director22024-03-311034283242ns10:Director22025-04-012026-03-311034283242ns10:Director22024-04-012025-03-311034283242ns10:Director22026-03-311034283242ns10:Director22025-03-3110342832ns5:CurrentFinancialInstruments2026-03-3110342832ns5:CurrentFinancialInstruments2025-03-3110342832ns5:ShareCapital2026-03-3110342832ns5:ShareCapital2025-03-3110342832ns5:RetainedEarningsAccumulatedLosses2026-03-3110342832ns5:RetainedEarningsAccumulatedLosses2025-03-3110342832ns10:RegisteredOffice2025-04-012026-03-3110342832ns5:FurnitureFittings2025-04-012026-03-3110342832ns5:FurnitureFittings2025-03-3110342832ns5:FurnitureFittings2026-03-3110342832ns5:FurnitureFittings2025-03-3110342832ns5:DeferredTaxation2025-03-3110342832ns5:DeferredTaxation2025-04-012026-03-3110342832ns5:DeferredTaxation2026-03-3110342832ns10:OrdinaryShareClass12026-03-3110342832ns10:OrdinaryShareClass22026-03-3110342832ns10:OrdinaryShareClass32026-03-3110342832ns10:OrdinaryShareClass42026-03-3110342832ns10:Director22025-04-012026-03-3110342832ns10:Director112025-03-3110342832ns10:Director112024-03-3110342832ns10:Director112025-04-012026-03-3110342832ns10:Director112024-04-012025-03-3110342832ns10:Director112026-03-3110342832ns10:Director112025-03-31
REGISTERED NUMBER: 10342832 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2026

for

Rassam Medical Consultancy Limited

Rassam Medical Consultancy Limited (Registered number: 10342832)






Contents of the Financial Statements
for the Year Ended 31 March 2026




Page

Balance Sheet 1

Notes to the Financial Statements 2


Rassam Medical Consultancy Limited (Registered number: 10342832)

Balance Sheet
31 March 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,709 1,366

CURRENT ASSETS
Debtors 5 3,819 4,750
Cash at bank 146,356 164,407
150,175 169,157
CREDITORS
Amounts falling due within one year 6 26,525 28,624
NET CURRENT ASSETS 123,650 140,533
TOTAL ASSETS LESS CURRENT
LIABILITIES

126,359

141,899

PROVISIONS FOR LIABILITIES 7 515 260
NET ASSETS 125,844 141,639

CAPITAL AND RESERVES
Called up share capital 8 103 103
Retained earnings 125,741 141,536
SHAREHOLDERS' FUNDS 125,844 141,639

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 June 2026 and were signed on its behalf by:



Dr S Rassam - Director


Rassam Medical Consultancy Limited (Registered number: 10342832)

Notes to the Financial Statements
for the Year Ended 31 March 2026

1. STATUTORY INFORMATION

Rassam Medical Consultancy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 10342832

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford Street
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2025 - 2 ) .

Rassam Medical Consultancy Limited (Registered number: 10342832)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1 April 2025 2,057
Additions 2,072
At 31 March 2026 4,129
DEPRECIATION
At 1 April 2025 691
Charge for year 729
At 31 March 2026 1,420
NET BOOK VALUE
At 31 March 2026 2,709
At 31 March 2025 1,366

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade debtors 3,819 4,750

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Tax 23,090 26,781
Social security and other taxes 104 (2 )
Directors' current accounts 1,489 165
Accrued expenses 1,842 1,680
26,525 28,624

7. PROVISIONS FOR LIABILITIES
31.3.26 31.3.25
£    £   
Deferred tax 515 260

Deferred
tax
£   
Balance at 1 April 2025 260
Provided during year 255
Balance at 31 March 2026 515

Rassam Medical Consultancy Limited (Registered number: 10342832)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2026

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.26 31.3.25
value: £    £   
100 Ordinary A £1 100 100
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
1 Ordinary D £1 1 1
103 103

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2026 and 31 March 2025:

31.3.26 31.3.25
£    £   
Dr S Rassam and Mrs N A M Rahou
Balance outstanding at start of year (165 ) (83 )
Amounts advanced 87,500 76,710
Amounts repaid (88,823 ) (76,792 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (1,488 ) (165 )

10. ULTIMATE CONTROLLING PARTY

The controlling party is Dr S Rassam.